The peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) has been associated with obesity and related metabolic disorders, affecting adipocyte differentiation and lipid metabolism (Zhang et al., 2022). Here, PPARGC1A is linked to metabolic disease.